Research Peptide
FOXO4-DRI is a senolytic peptide being investigated for its ability to selectively target and remove senescent (“aging”) cells. Research suggests senescent cell clearance may support healthy aging, tissue regeneration, and overall cellular function. FOXO4-DRI remains an experimental compound intended for research use only.
Reviews
There are no reviews yet.